NP89
NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
12/09/2025
Back to search
Official data from USPTO
ACURA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACURA PHARMACEUTICALS
ST13
US500000078375565Class
5, 42
Filing
78375565
Registration
3114970
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
12/30/2025
Trademark type
Word
Nice classes
5, 42
Filing date
02/27/2004
Registration date
07/11/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/09/2025
Last transaction
12/30/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/29/2004
First use in commerce
03/29/2004
Drawing code
4
Owner type
03
Owner location
PALATINE, IL
Examiner
SUSSMAN, RONALD
Holders and representatives
Holders
ACURA PHARMACEUTICALS, INC.
Halsey Drug Co. Inc.
Representatives
W. Drew Kastner Offit Kurman, P.A.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations to be used in opioid-containing pharmaceuticals to minimize the possibility of abuse and addiction to the opioid-containing pharmaceuticals
Class 42
Pharmaceutical research and development services
Publications
History of USPTO decisions and trademark events.
44 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12/09/2025
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
12/09/2025
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
12/09/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/09/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/22/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/22/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/22/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
08/27/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/11/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/28/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/28/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/28/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/28/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
07/11/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/11/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/15/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/14/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/14/2012
E815
TEAS SECTION 8 & 15 RECEIVED
07/05/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/16/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/16/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2006
DOCK
ASSIGNED TO EXAMINER
06/08/2006
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/25/2006
ALIE
ASSIGNED TO LIE
05/19/2006
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/16/2006
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/23/2005
IUAF
USE AMENDMENT FILED
09/16/2005
EISU
TEAS STATEMENT OF USE RECEIVED
09/16/2005
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/15/2005
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
05/10/2005
PUBO
PUBLISHED FOR OPPOSITION
02/15/2005
NPUB
NOTICE OF PUBLICATION
01/26/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/15/2004
ALIE
ASSIGNED TO LIE
12/10/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/26/2004
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/12/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2004
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/03/2004
GNRT
NON-FINAL ACTION E-MAILED
09/03/2004
CNRT
NON-FINAL ACTION WRITTEN
09/03/2004
DOCK
ASSIGNED TO EXAMINER
09/01/2004
NWAP
NEW APPLICATION ENTERED
03/16/2004
Continuous trademark protection
Get notified about every new filing that threatens ACURA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.